Renal Pre-Competitive Consortium (RPC 2 ): discovering therapeutic targets together.

•The Renal Pre-Competitive Consortium (RPC2) aims to accelerate novel drug development for kidney diseases through a systems biology approach.•Contract details addressing intellectual property and data sharing are essential in establishing a pre-competitive consortium.•The partners in the RPC2 share the vision, resources, expertise and contribute to the common goals of the consortium.•Pre-competitive consortia flourish when vision and needs are aligned amongst partners.